氨基酸转运蛋白是一类膜蛋白,负责在细胞内外之间转运氨基酸,对维持细胞内外氨基酸浓度平衡至关重要。SLC3 和 SLC7家族是两类研究较深入的氨基酸转运蛋白 ,SLC7 阳离子氨基酸转运蛋白 (CATs) 和 L 型氨基酸转运蛋白 (LATs),LATs 通常与SLC3 家族的重链亚单位通过二硫键形成异源二聚体,即异源氨基酸转运蛋白 (HATs)。
氨基酸转运蛋白参与调节细胞内信号途径,如哺乳动物雷帕霉素靶蛋白复合体1 (mTORC1) 和全局控制非抑制 (GCN) 途径,通过调控这些信号途径来影响蛋白质合成、细胞增殖和生长。氨基酸转运蛋白的功能异常与遗传性氨基酸尿症、肿瘤生长以及肠道和肾脏的吸收障碍等疾病有关。特定的转运蛋白,如 LAT1 和 SLC7A5,在肿瘤细胞的增殖和代谢中扮演关键角色,可作为潜在的药物靶标[1][2]。
Amino acid transporters are a class of membrane proteins responsible for transporting amino acids between the inside and outside of cells, crucial for maintaining the balance of amino acid concentrations. The SLC3 and SLC7 families are two well-studied classes of amino acid transporters. The SLC7 family includes cationic amino acid transporters (CATs) and L-type amino acid transporters (LATs), with LATs typically forming heterodimeric complexes with the heavy chain subunits of the SLC3 family through disulfide bonds, known as heteromeric amino acid transporters (HATs).
Amino acid transporters are involved in regulating intracellular signaling pathways such as the mammalian target of rapamycin complex 1 (mTORC1) and the general control non-derepressible (GCN) pathways, influencing protein synthesis, cell proliferation, and growth through the regulation of these signaling pathways. Dysfunctions in amino acid transporters are associated with diseases such as hereditary aminoaciduria, tumor growth, and absorption disorders in the intestines and kidneys. Specific transporters, like LAT1 and SLC7A5, play crucial roles in the proliferation and metabolism of tumor cells and can serve as potential drug targets[1][2].
SXC2023 是一种谷氨酸能试剂和胱氨酸-谷氨酸反向转运体 (System xc−) 激活剂,可影响 SLC7A11,具有神经活性,并可用于结直肠癌和拔毛癖的研究。
SZ0232 是一种选择性 mPGES-2 抑制剂,它通过氢键和 π-π 堆叠结合至 mPGES-2 活性位点,减少前列腺素 E2 (PGE2) 生成并阻断 PGE2-EP3 通路,同时通过激活血红素依赖的 p53/SLC7A11/GPX4 轴调控铁死亡 (Ferroptosis)、抑制脂质过氧化并保护肾小管,还可增强葡萄糖刺激的胰岛素分泌、抑制 β 细胞衰老、改善葡萄糖稳态,减少糖尿病小鼠的肾脏脂质蓄积、减轻纤维化并改善肾功能障碍,在多囊肾病模型中抑制肾囊肿生长,其促胰岛素分泌效应随动物年龄增长而增强,可用于 2 型糖尿病、急性肾损伤、糖尿病肾病及常染色体显性多囊肾病的相关研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号